1,533
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Simple peripheral markers for inflammation in adolescents with major depressive disorder

, &
Pages 254-260 | Received 27 Nov 2017, Accepted 28 Dec 2017, Published online: 17 Jan 2018

ABSTRACT

OBJECTIVE: Neutrophil–lymphocyte ratio (NLR), platelet–lymphocyte ratio (PLR), mean platelet volume (MPV), and red cell distribution width (RDW) were determined to be good indicators of inflammatory status. The aim of this study was to investigate NLR, PLR, MPV, and RDW, which can provide insight into diagnosis and/or prognosis in adolescents with major depressive disorder (MDD) compared to controls.

METHOD: A total of 103 patients diagnosed with MDD, who received no antidepressant therapy within the past 1 month, were included in the study. The control group consisted of 41 healthy subjects with no organic and psychiatric disorders.

RESULTS: NLR and MPV values were significantly high in adolescents with MDD compared with healthy controls (2.00 ± 0.80 vs. 1.63 ± 0.64, P = .011; 10.25 ± 0.91 vs. 9.62 ± 1.23, P = .005). There was no difference between the groups on PLR and RDW. There was a positive correlation between NLR and Children’s Depression Scale (CDI) scores in the total study group (r = 0.229, P = .006). There was also a positive correlation between MPV and CDI scores in the total study group (r = 0.185, P = .028).

CONCLUSION: The findings of the study reveal that NLR and MPV tend to be higher in adolescents with MDD, and higher NLR values are associated with higher CDI scores in adolescents. The findings of this study are consistent with the relevant literature of inflammatory status in MDD. Our study gave us an idea of the need for larger sample study on the routine use of blood parameters in adolescent depression.

Introduction

Depression is a common disease affecting the quality of life in children and adolescents [Citation1]. The prevalence of major depressive disorder (MDD) in adolescents is 4–8% [Citation2]. Many factors play role in the aetiology of MDD [Citation3]. Studies investigating the role of the immune system in the aetiology of MDD have increased in lately [Citation4]. It has been suggested that MDD suppresses the immune system and may also increase pro-inflammatory cytokines. Acute phase reactants and pro-inflammatory cytokines such as interleukin-1 (IL-1), interleukin-6 (IL-6), and tumour necrosis factor-alpha (TNF-alpha) may play a role in the aetiology of depression [Citation5–7]. In addition, antidepressants have been demonstrated to reduce and normalize levels of pro-inflammatory cytokines [Citation7,Citation8].

In clinical practice, it has been reported that haemogram parameters such as the neutrophil–lymphocyte ratio (NLR), platelet–lymphocyte ratio (PLR), mean platelet volume (MPV), and red cell distribution width (RDW) can be used as markers of systemic inflammation for different diseases [Citation9–11]. NLR and PLR are calculated as absolute counts of neutrophils, platelets, and lymphocytes in haemogram; thus, inflammation can easily be measured in routine blood tests [Citation12,Citation13]. Inflammation can cause an increase in the number and activity of neutrophils and platelets, while apoptosis process characterized by the reduction of lymphocytes [Citation14,Citation15]. Platelet volume is defined as the number of megakaryocytes present during platelet production, which is related to platelet function and activation. The number of platelets and their size are negatively correlated [Citation16,Citation17]. Large platelet sizes reflect increased thrombocyte reactivity and reactive thrombocytes play an important role in inflammatory processes [Citation18]. RDW, as part of a complete blood cell count, is measured by an automatic haematology analyser and estimates erythrocytic variability. Increased RDW reflects ineffective erythropoiesis, which may be a consequence of systemic inflammation [Citation19]. NLR, PLR, MPV, and RDW have been determined to be potential markers for testing inflammation in many disorders. NLR has been investigated in children and adolescents with asthma [Citation20] and allergic rhinitis [Citation21], MPV has investigated in children with asthma [Citation22] and obstructive apnoea syndrome [Citation23], and RDW has been investigated in children with acute appendicitis [Citation24], acute rheumatic carditis [Citation25], and sepsis [Citation26]. The association between NLR, PLR, and MPV obesity in adolescents has also been reported in the literature [Citation27]. There are also studies on adolescents investigating the effects of diet and exercise on NLR in overweight adolescents [Citation28], and the relationship between NLR, PLR, MPV, and RDW and ovarian neoplasm [Citation29] and the relationship between MPV and primary dysmenorrhea [Citation30].

Recently, increased attention has been paid to haemogram parameters in mood disorders [Citation31,Citation32]. Other systemic inflammation markers reported in studies are generally expensive and require special equipment [Citation33–35]. However, haemogram parameters, such as NLR, PLR, MPV, and RDW, are less expensive and can easily be detected. NLR, RDW, and PLR have been investigated in adult MDD patients [Citation36–40], while MPV has been investigated in patients with bipolar disorder [Citation41]. However, only one study has examined MPVs in children with attention-deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) [Citation42]. These parameters have been widely studied in adult but not adolescent psychiatric patients, although they have been investigated in children with various non-psychiatric organic diseases. Thus, we hypothesized that these haemogram parameters which can provide insight into diagnosis and/or prognosis may exhibit significant differences in adolescent depression. To the best of our knowledge, there has been no study investigating NLR, PLR, MPV, and RDW in adolescent MDD patients. Therefore, we aimed to compare the routine haemogram values of treatment-naive adolescent MDD patients with those of a healthy control group to evaluate inflammation levels in both groups.

Materials and methods

Study population

This study included 103 adolescents diagnosed with MDD based on semi-structured interviews carried out by a child psychiatrist on individuals who applied to the Children and Adolescent Psychiatry Outpatient Clinic of Van Education and Training Hospital between January 1 and March 31 2017. The control group consisted of 41 adolescents who applied to the Department of Pediatrics voluntarily and were not diagnosed with any physical or mental disorder. The control group of adolescents was matched with the patient group by age, gender, and body mass index (BMI) to prevent any effects on the haemogram variables. The necessary legal permission and approval were obtained from the Van Education and Training Hospital Ethics Committee before proceeding to the data collection stage (October 10 2016, no.: 2016/10). All participants in the study and their parents gave informed consent after being informed of the methods and objectives of this study. Haemogram samples of adolescents experiencing their first depressive episode were taken prior to medical treatment. Adolescents with comorbid psychiatric diseases, chronic or inflammatory diseases, local or systemic infection in the last month, alcohol or substance users, smokers and drug users were excluded. Obesity (BMI >30 kg/m2) is also an exclusion criterion due to chronic systemic inflammation in the metabolic syndrome etiopathogenesis [Citation43]. Children’s lengths and weights were measured by the same paediatric nurse before the examination. BMI was assessed by the researchers during their examination. The adolescents were initially requested to fill out a socio-demographic questionnaire prepared by the researchers, and then were evaluated by child and adolescent psychiatrists using the Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS) for psychopathology (Affective Disorders and Schizophrenia Schedule for School Age Children Present and Lifetime). The severity of depression was assessed using the Children’s Depression Scale (CDI). Blood was taken for biochemical analyses.

Data form descriptions

Information collection form

Information Collection Form (ICF) was created by the researchers. The ICF surveyed adolescents regarding their socio-demographic characteristics, including age and gender, and presence of chronic disease, smoking, alcohol, and/or drug use.

Kiddie schedule for affective disorders and schizophrenia–present and lifetime version (K-SADS-PL)

K-SADS-PL is a semi-structured diagnostic interview regarding the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders. It was developed by Kaufman et al. [Citation44] and has been translated into Turkish. A validity and reliability study of the schedule for Turkish children was conducted by Gökler et al. [Citation45].

Children’s Depression Scale

Children’s Depression Scale was developed by Kovacks based on the Beck Depression Scale [Citation46]. The validity and reliability study in our country was made by Öy [Citation47]. The self-report scale includes 27 items that can be applied to children and adolescents between the ages of 6 and 17. Each item is scored 0–2 according to depression severity. The scale maximum score is 54. High scores indicate the severe depression. The cut-off value of scale is determined as the value of 19.

Blood sampling and haemogram measurements

For blood samples, participants were invited to an outpatient clinic at 9 a.m. with 12 hours of hunger 12. The samples were taken from the participants’ antecubital veins and stored in haemogram tubes. Blood tests were performed in the Van Education and Training Hospital Central Laboratory using a Sysmex XN1000. The manufacturer of Sysmex XN1000 is Sysmex Corporation from Kobe, Japan. The intra- and inter-assay CVs of WBCs were <3.0% and <4.0%, respectively. The intra- and inter-assay CVs of neutrophils and lymphocytes were <8.0% and <16.0%, respectively. The intra- and inter-assay CVs of platelets were <4.0% and <12.0%, respectively. The intra- and inter-assay CVs of MPVs were <4.0% and <8.0%, respectively. The intra- and inter-assay CVs of RDWs were <2.0% and <6.0%, respectively.

Statistical analysis

Data were evaluated using IBM SPSS Statistics 22.0 statistical software package program. The mean and the standard deviation values with minimal and maximal levels were used for the statistical expression of the groups. Whereas the comparison of the continuous variables between the groups was performed using the Student’s t-test for normally distributed variables, comparison of abnormally distributed variables and nonparametric parameters was performed using the Mann–Whitney U-test. Comparison of the categorical variables of the groups was performed using chi-square tests. A Pearson correlation analysis was carried out to analyse correlations. A P value of <.05 was considered statistically significant.

Results

The age, sex, and BMI of all patient groups were compared with control subjects. The mean ages of patient group (15.64 ± 1.28) and the control group (15.24 ± 1.17) were similar; 68.9% (n = 71) of the patient group and 53.7% (n = 22) of the control group were girls. The distribution of sex between the groups was homogenic. The BMI of patient group (20.24 ± 3.19) and the control group (19.77 ± 3.26) were similar in terms of average. The properties of participants were shown in .

Table 1. Socio-demographic characteristics of the participants.

The laboratory findings for the two study groups are presented in . NLR (effect size d = 0.51, r = 0.24), MPV (effect size d = 0.58, r = 0.27), WBC (effect size d = 0.53, r = 0.25), neutrophil (effect size d = 0.56, r = 0.27), MCV (effect size d = 0.62, r = 0.29), and MCH values of the adolescents with MDD were significantly higher than those of the control group. RBC values of the control group were significantly higher than those of the adolescents with MDD. There were no differences between the two groups in terms of PLR, RDW, lymphocyte, haemoglobin, HCT, MCHC, platelets, and PCT values.

Table 2. Laboratory findings for the patient and control group participants.

The patient group (26.98 ± 7.17) had significantly higher CDI scores than the control group (11.0 ± 5.98) (P < .001, t = 12.590) (effect size d = 2.42, r = 0.77). Correlations between the CDI scores and NLR, PLR, MPV, and RDW were identified for all participants taken as a whole. There were positive correlations between CDI scores and NLR and between CDI scores and MPV for all participants. The results of these analyses can be found in .

Table 3. Pearson’s correlation coefficients for each pair of variables.

Discussion

In our study, we aimed to assess haemogram parameters to determine the inflammation status of adolescents with MDD by comparison with their healthy peers. The results of this study indicated that the NLR and MPV values in adolescents with MDD were higher than those of their healthy peers and there was no difference between the groups on PLR and RDW. In addition, a positive correlation between NLR, MPV values and depression scores in adolescents was observed.

The role of inflammation is important in the aetiology of MDD [Citation48] and studies have reported that inflammation is increased in patients with depression [Citation49,Citation50]. However, the relationship between inflammatory markers and depression is still unclear. When we consider inflamatuar markers or alterations have a causative role in MDD aetiology, marker levels are a consequence of psychological distress in MDD. Cytokines associated with inflammation affect the pathophysiology of depression by altering the metabolism of relevant neurotransmitters, neuroendocrine functions, and synaptic plasticity [Citation5,Citation51,Citation52]. Pro-inflammatory cytokines may affect monoamine metabolism. Serotonin transporter mRNA and proteins are upregulated by the cytokines such as IL-1, IL-6, and TNF-α cytokines, thus causes the decreases in free serotonin. The relationship between serotonin/serotonin transporters and inflammation has received attention in the aetiology of depression [Citation51]. On the other hand, it has been stated that potential mediators of inflammation markers, including leukocytes, neutrophils, complements, and C-reactive proteins increase in response to depression [Citation53]. Previous studies have showed that patients with depression have reduced lymphocyte answers to mitogen stimulation and disorders in neutrophil activity [Citation54–56]. In general, the findings of our study are consistent with those of previous studies, indicating increased neutrophil and leukocyte counts in adolescents with depression. Therefore, we conclude that adolescent depression is associated with inflammation, although the exact nature of the relationship and the mechanisms involved are not yet fully understood.

Studies have indicated that NLR values are higher in inflammatory disease of children, such as asthma, allergic rhinitis, and obese adolescents [Citation20,Citation21,Citation27]. No study to date concerning this subject has been carried out in children and adolescent with psychiatric disorders. Studies regarding adult depression have reported significantly higher NLR rates in patients with depression [Citation38,Citation40]; however, there has also been at least one study that reported findings to the contrary [Citation36]. In our study, NLR values were significantly higher in adolescents with depression than in healthy controls. These results also support the conclusion that evaluating NLR rather than neutrophil or lymphocyte counts, used in previous studies, would be beneficial for adolescents with depression [Citation38]. We thought that if these results supported in large sample studies, this simple method may be taken into consideration during the assessment of patients with depression by adolescent psychiatrists.

In a study conducted in adult depressed patients, there was no significant difference between the patient group and the control group in terms of PLR ratios [Citation40]. In studies investigating PLR values in adolescents, there was no significant difference in PLR values between obese adolescents and non-obese adolescents, nor was there a difference between those with and without primary dysmenorrhoea [Citation27,Citation30]. Our finding is in line with these studies in terms of PLR. Nevertheless, we did not find a difference with regard to PLR in MDD patients relative to controls. Some researchers have determined NLR to be a more reliable marker for subclinical inflammation when compared to PLR [Citation57]. As our study also found no association between inflammation and PLR, we recommend the use of NLR rather than PLR as a marker of inflammation in adolescents with depression.

Studies have found elevated MPV levels in obese adolescents, children with asthma, and children with obstructive sleep apnoea syndrome when compared with those of healthy subjects [Citation22,Citation23,Citation27]; thus, MPV is considered an inflammation marker. A previous study reported no relationships between MPV levels and children with ADHD and children with ASD [Citation42], although another study reported increased MPV levels in adult MDD patients [Citation58]. Our finding is compatible with the adult MDD study in terms of MPV. This result suggests that similar to NLR, if these results supported in large sample studies, MPV could be used as a marker of inflammation in adolescents with MDD.

RDW values were found to be significantly higher in children with acute appendicitis and acute rheumatic carditis when compared with those of healthy controls [Citation24,Citation25]. A study conducted by adult patients with depression has reported significantly higher RDW values in the patients with depression compared to the healthy controls [Citation40]. In a study evaluating iron deficiency in children and adolescents with ADHD and healthy controls, there was no significant difference in the RDW values of the ADHD group compared to the control group [Citation59]. In another study investigating inflammation in autistic children, no significant difference was reported in the mean RDW of the patient group when compared with that of the healthy group [Citation60]. In studies evaluating RDW in children and adolescents with organic disease and in adult patients with depression, RDW has been shown to be associated with inflammation; however, studies evaluating RDW in children and adolescents with ADHD and autism have not shown significant results. Our results also found no significant difference in RDW levels in adolescents with depression compared to their healthy peers. This result suggests that RDW in children and adolescents may be an indication of inflammation due to organic disease; however, there is insufficient data regarding inflammation in psychiatric diseases.

In a study evaluating the relationship between haemogram parameters and disease severity in children with asthma, a poor correlation was found between NLR and hospitalization [Citation20]. In another study in which NLR was assessed in children with allergic rhinitis, those with moderate to severe symptoms had higher NLR than those with mild symptoms [Citation21]. In a study investigating NLR in adolescents with primary dysmenorrhea, there was no significant difference in terms of PLR and NLR, although adolescents with severe primary dysmenorrhea had a significantly lower MPV levels than the control group [Citation30]. In a study of MPV values in children with asthma, the MPV levels of the group with exacerbated asthma were found to be significantly lower than those of the stable asthma group; however, there was no significant difference between the exacerbated asthma group and the control group [Citation22]. In a study evaluating RDW in children with paediatric acute appendicitis, there was no significant difference in the RDW values of those with perforated appendicitis cases and those with simple appendicitis cases [Citation24]. In a study of adult patients with depression, a positive significant correlation was reported between NLR and depression severity [Citation39]; however, another study reported no correlation between NLR and depression severity [Citation38]. In another study on adult patients with depression, PLR values were found to be significantly higher in psychotic depressive patients than in other patients, although there was no correlation between NLR and depression severity [Citation37]. As can be seen, when we examine the literature, there is a significant relationship between NLR and disease severity for non-psychiatric diseases. In the case of psychiatric diseases, there were contradictory findings on NLR in adult patients, and only one study shows a positive correlation between depression severity and PLR. This suggests that our results, in particular, the correlation between NLR and disease severity, may enhance our understanding of the relationship between inflammation and adolescent depression.

It is unclear that if inflammation markers were trait markers (diagnostic or diathetic), or state markers. When we examined the literature regarding the relationship between immune response and severity of depression, there were studies which were reported positive [Citation56] and negative correlations [Citation61] between them. There were also studies which showed no correlation between them [Citation62,Citation63]. While there is only one study which concerned a positive correlation between NLR and severity of depression [Citation39], there are some studies which did not support this finding [Citation37,Citation38]. On the other hand, studies which were conducted with the adult depression patients have stated a significant increase in inflammation markers in MDD [Citation38,Citation64]. There was also a study which showed no significant increase than controls [Citation36]. In our study, there was a significant increase than the control group in terms of NLR and MPV, and also these markers were correlated with severity of depression. Further studies with larger numbers of adolescents with MDD are needed to clarify whether inflammation markers are useful for clinicians in the diagnosis and follow-up of adolescents with MDD.

The present study has several limitations. Firstly, it would be more informative to design as a prospective study, evaluating the relationship between the treatment of depression and haemogram parameters than cross-sectional study. Since we could not define the subtype of depression for each patient, we could not evaluate the relationship between it and haemogram parameters. Another limitation is that we could not analyse the lymphocyte subtypes and cytokines in combination with haemogram parameters. Our information regarding alcohol/ substance usage, smoking, and chronic/ inflammatory diseases of subjects depends on adolescent and parent report. This may cause subjective information. One of the potential limitations of our study is that control groups were not matched with the study group in terms of number of participants, despite the patient group was large enough. Despite these limitations, our study is of critical importance as it is the first study in which NLR, PLR, MPV, and RDW were investigated in adolescents with MDD.

Conclusion

In our study, NLR and MPV tend to be higher in adolescents with MDD and higher CDI scores were associated with higher NLR and MPV levels in adolescents with MDD. A simple inexpensive blood cell count may also help clinicians evaluate the severity of depression. We suggest that this simple blood test can give the clinician an opinion about the presence of the inflammatory process in depression. Further research is necessary to fully understand the role of inflammation in the aetiology and treatment of depression, and follow-up studies should focus on the process of inflammation in psychiatric diseases in children and adolescents.

Disclosure statement

No potential conflict of interest was reported by the authors.

References

  • Costello EJ, Pine DS, Hammen C, et al. Development and natural history of mood disorders. Biol Psychiatry. 2002;52(6):529–542.
  • Birmaher B, Brent D, AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry. 2007;46(11):1503–1526.
  • Myint AM, Kim YK. Cytokine–serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses. 2003;61(5):519–525.
  • Tuğlu C, Kara SH. Depression, cytokines and immune system. Bull Clin Psychopharmacol. 2003;13(3):142–150.
  • Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27(1):24–31.
  • Krishnadas R, Cavanagh J. Depression: an inflammatory illness? J Neurol Neurosurg Psychiatry. 2012;83(5):495–502.
  • Hannestad J, DellaGioia N, Bloch M. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology. 2011;36(12):2452–2459.
  • Janssen DGA, Caniato RN, Verster JC, et al. A psychoneuroimmunological review on cytokines involved in antidepressant treatment response. Hum Psychopharmacol Clin Exp. 2010;25(3):201–215.
  • Kuyumcu ME, Yesil Y, Oztürk ZA, et al. The evaluation of neutrophil-lymphocyte ratio in Alzheimer’s disease. Dement Geriatr Cogn Dis Extra. 2012;34(2):69–74.
  • Boyraz İ, Koç B, Boyacı A, et al. Ratio of neutrophil/lymphocyte and platelet/lymphocyte in patient with ankylosing spondylitis that are treating with anti-TNF. JDR Clin Trans Res. 2014;7(9):2912.
  • Kilincalp S, Çoban Ş, Akinci H, et al. Neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and mean platelet volume as potential biomarkers for early detection and monitoring of colorectal adenocarcinoma. Eur J Cancer Prev. 2015;24(4):328–333.
  • Balta S, Demırkol S, Kucuk U. The platelet lymphocyte ratio may be useful inflammatory indicator in clinical practice. Hemodial Int. 2013;17(4):668–669.
  • Bhat T, Teli S, Rijal J, et al. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther. 2013;11(1):55–59.
  • Zahorec R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102(1):5–14.
  • Balta S, Ozturk C. The platelet-lymphocyte ratio: a simple, inexpensive and rapid prognostic marker for cardiovascular events. Platelets. 2015;26(7):680–681.
  • Jackson SR, Carter JM. Platelet volume: laboratory measurement and clinical application. Blood Rev. 1993;7(2):104–113.
  • Threatte GA. Usefulness of the mean platelet volume. Clin Lab Med. 1993;13(4):937–950.
  • Yuri Gasparyan A, Ayvazyan L, Mikhailidis PD, et al. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des. 2011;17(1):47–58.
  • Förhécz Z, Gombos T, Borgulya G, et al. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J. 2009;158(4):659–666.
  • Dogru M, Yesiltepe Mutlu RY. The evaluation of neutrophil–lymphocyte ratio in children with asthma. Allergol Immunopathol. 2016;44(4):292–296.
  • Dogru M, Evcimik MF, Cirik AA. Is neutrophil–lymphocyte ratio associated with the severity of allergic rhinitis in children? Eur Arch Otorhinolaryngol. 2016;273(10):3175–3178.
  • Dogru M, Aktas A, Ozturkmen S. Mean platelet volume increased in children with asthma. Pediatr Allergy Immunol. 2015;26(8):823–826.
  • Soyalıç H, Somuk BT, Doğru S, et al. Evaluation of mean platelet volume and its ratio over platelet count in children with obstructive sleep apnea syndrome. Kulak Burun Bogaz Ihtisas Dergisi: KBB=Journal of Ear, Nose, and Throat. 2015;25(1):16–21.
  • Bozlu G, Taskinlar H, Unal S, et al. Diagnostic value of red blood cell distribution width in pediatric acute appendicitis. Pediatr Int. 2016;58(3):202–205.
  • Kucuk M, Ozdemir R, Karadeniz C, et al. Red blood cell distribution width: can it be a predictive marker for long-term valvular involvement in children with acute rheumatic carditis? Int J Lab Hematol. 2016;38(5):569–575.
  • Ramby AL, Goodman DM, Wald EL, et al. Red blood cell distribution width as a pragmatic marker for outcome in pediatric critical illness. PloS One. 2015;10(6):e0129258.
  • Aydin M, Yilmaz A, Donma MM, et al. Neutrophil/lymphocyte ratio in obese adolescents. North Clin Istanb. 2015;2(2):87.
  • Wang R, Chen P, Chen W. Diet and exercise improve neutrophil to lymphocyte ratio in overweight adolescents. Int J Sports Med. 2011;32(12):982–986.
  • Ozaksit G, Tokmak A, Kalkan H, et al. Value of the platelet to lymphocyte ratio in the diagnosis of ovarian neoplasms in adolescents. Asian Pac J Cancer Prev. 2015;16(5):2037–2041.
  • Kucur SK, Seven A, Yuksel KB, et al. Mean platelet volume, a novel biomarker in adolescents with severe primary dysmenorrhea. J Pediatr Adolesc Gynecol. 2016;29(4):390–392.
  • Rosenblat JD, Brietzke E, Mansur RB, et al. Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: evidence, pathophysiology and treatment implications. J Affect Disord. 2015;188:149–159.
  • Anderson G, Maes M. Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites. Curr Psychiatry Rep. 2015;17(2):329–329.
  • Reichenberg A, Yirmiya R, Schuld A, et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry. 2001;58(5):445–452.
  • Wright CE, Strike PC, Brydon L, et al. Acute inflammation and negative mood: mediation by cytokine activation. Brain Behav Immun. 2005;19(4):345–350.
  • Boufidou F, Nikolaou C, Alevizos B, et al. Cytokine production in bipolar affective disorder patients under lithium treatment. J Affect Disord. 2004;82(2):309–313.
  • Korkmaz S, Atli A, Bulut M, et al. Neutrophil lymphocyte ratio in patients with major depressive disorder. Acta Med Mediterr. 2016;32(3):795–798.
  • Kayhan F, Gündüz Ş, Ersoy SA, et al. Relationships of neutrophil–lymphocyte and platelet–lymphocyte ratios with the severity of major depression. Psychiatry Res. 2017;247:332–335.
  • Demir S, Atli A, Bulut M, et al. Neutrophil–lymphocyte ratio in patients with major depressive disorder undergoing no pharmacological therapy. Neuropsychiatr Dis Treat. 2015;11:2253.
  • Aydin Sunbul E, Sunbul M, Yanartas O, et al. Increased neutrophil/lymphocyte ratio in patients with depression is correlated with the severity of depression and cardiovascular risk factors. Psychiatry Invest. 2016;13(1):121–126.
  • Peng Y-F, Zhong SM, Luo B, et al. Evaluation of red blood cell distribution width and neutrophil to lymphocyte ratio in patients with major depressive disorder. Int J Clin Exp Med. 2016;9(2):3242–3246.
  • Mert DG, Terzi H. Mean platelet volume in bipolar disorder: the search for an ideal biomarker. Neuropsychiatr Dis Treat. 2016;12:2057.
  • Garipardic M, Doğan M, Bala KA, et al. Association of attention deficit hyperactivity disorder and autism spectrum disorders with mean platelet volume and vitamin D. Med Sci Monit. 2017;23:1378.
  • Lee Y-H, Pratley RE. The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep. 2005;5(1):70–75.
  • Kaufman J, Birmaher B, Brent D, et al. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL):initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36(7):980–988.
  • Gökler B, Ünal F, Pehlivantürk B, et al. Reliability and validity of schedule for affective disorders and schizophrenia for school age children-present and lifetime version-turkish version (K-SADS-PL-T). Çocuk ve Gençlik Ruh Sağlığı Dergisi/Turkish Journal of Child and Adolescent Mental Health. 2004;11(3):109–116.
  • Kovacs M. The children's depression inventory (CDl). Psychopharmacol Bull. 1985;21:995–998.
  • Öy, B. Çocuklar için depresyon ölçeği: geçerlik ve güvenirlik çalışması. Türk Psikiyatri Dergisi. 1991;2(2):132–136.
  • Sadock BJ, Sadock VA. Kaplan and Sadock’s synopsis of psychiatry: behavioral sciences/clinical psychiatry. Philadelphia(PA): Lippincott Williams & Wilkins; 2011.
  • Leonard BE. The immune system, depression and the action of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry. 2001;25(4):767–780.
  • Raison CL, Miller AH. Is depression an inflammatory disorder? Curr Psychiatry Rep. 2011;13(6):467–475.
  • Maes M, Ringel K, Kubera M, et al. Increased autoimmune activity against 5-HT: a key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depression. J Affect Disord. 2012;136(3):386–392.
  • Raedler TJ. Inflammatory mechanisms in major depressive disorder. Curr Opin Psychiatry. 2011;24(6):519–525.
  • Kiecolt-Glaser JK, Marucha PT, Mercado AM, et al. Slowing of wound healing by psychological stress. The Lancet. 1995;346(8984):1194–1196.
  • Sertöz ÖÖ, HE M. Bedensel hastalıklarda depresyon. Klinik Psikiyatri Dergisi. 2004;7(Suppl 2):S63–SS9.
  • Rothermundt M, Arolt V, Fenker J, et al. Different immune patterns in melancholic and non-melancholic major depression. Eur Arch Psychiatry Clin Neurosci. 2001;251(2):90–97.
  • Miller GE, Cohen S, Herbert TB. Pathways linking major depression and immunity in ambulatory female patients. Psychosom Med. 1999;61(6):850–860.
  • Özer S, Yılmaz R, Sönmezgöz E, et al. Simple markers for subclinical inflammation in patients with familial Mediterranean fever. Med Sci Monit. 2015;21:298–303.
  • Canan F, Dikici S, Kutlucan A, et al. Association of mean platelet volume with DSM-IV major depression in a large community-based population: the MELEN study. J Psychiatric Res. 2012;46(3):298–302.
  • Seleem MA, El-Gohary TM, Eid MA, et al. Serum ferritin is negatively correlated with inattention in a sample of Egyptian children with attention deficit hyperactivity disorder. Arab J Psychiatry. 2014;25(2):96–106.
  • Tonhajzerova I, Ondrejka I, Mestanik M, et al. Inflammatory activity in autism spectrum disorder, in respiratory health. Cham: Springer; 2015. p. 93–98.
  • Mittwoch-Jaffe T, Shalit F, Srendi B, et al. Modification of cytokine secretion following mild emotional stimuli. Neuroreport. 1995;6(5):789–792.
  • Schleifer SJ, Keller SE, Bartlett JA, et al. Immunity in young adults with major depressive disorder. Am J Psychiatry. 1996;153(4):477–482.
  • Ravindran AV, Griffiths J, Merali Z, et al. Circulating lymphocyte subsets in major depression and dysthymia with typical or atypical features. Psychosom Med. 1998;60(3):283–289.
  • Demircan F, Gözel N, Kılınç F, et al. The impact of red blood cell distribution width and neutrophil/lymphocyte ratio on the diagnosis of major depressive disorder. Neurol Ther. 2016;5(1):27–33.